Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China

OBJECTIVE: To evaluate the safety of primary immunization using CoronaVac® among population aged 3 years and above in a large-scale use. METHOD: A multi-center open-label study was carried out in 11 provinces of China. Individuals aged 3 years and older who had no history of COVID-19 vaccination or...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haitao, Li, Zhen, Zhang, Ruizhi, Guo, Shicheng, Wang, Binbing, Fang, Xing, Zhang, Dongjuan, Zhang, Xiaoshu, Tong, Yeqing, Wang, Qing, Deng, Qiuyun, Sun, Zhaodan, Liu, Xiaoqiang, Gao, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837223/
https://www.ncbi.nlm.nih.gov/pubmed/36658045
http://dx.doi.org/10.1016/j.vaccine.2023.01.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837223/
https://www.ncbi.nlm.nih.gov/pubmed/36658045
http://dx.doi.org/10.1016/j.vaccine.2023.01.020

Ejemplares similares